Screener
Cogent Biosciences, Inc. COGT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
FAQ
- What is Cogent Biosciences, Inc.'s enterprise value?
- Cogent Biosciences, Inc. (COGT) reported enterprise value of $6.02B in Q1 2026.
- How has Cogent Biosciences, Inc.'s enterprise value changed year-over-year?
- Cogent Biosciences, Inc.'s enterprise value increased by 950.8% year-over-year, from $573.05M to $6.02B.
- What is the long-term trend for Cogent Biosciences, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s enterprise value has grown at a 89.6% compound annual growth rate (CAGR), from $210.54M to $5.16B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Cogent Biosciences, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude